Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

One step further toward treatment for degenerative diseases

18.05.2004


Scientists identify a key mechanism to recognize misfolded proteins



Scientists at McGill University’s Faculty of Medicine have discovered a key step that will provide new targets for treatments of many degenerative diseases such as Alzheimer’s, Cystic Fibrosis and Diabetes. Dr. David Thomas, Chair of Biochemistry, Dr. John Bergeron, Chair of Anatomy and Cell Biology and colleagues have identified a mechanism by which misfolded proteins are recognized in the cell. This is a critical process as proteins that are not correctly folded or shaped are extremely harmful to cells and are the basis for a number of human degenerative diseases. The findings were published in the prestigious journal Nature Structural and Molecular Biology.

"We have identified a central enzyme that is sensitive to very subtle changes in the folded state of a protein," explained Dr. David Thomas. "Proteins are the building blocks and machines of our bodies. In order for them to work correctly they have to fit together. Cells in our bodies have developed quality control mechanisms to assure proper folding. When something goes wrong, cells can accumulate misfolded proteins that don’t work properly. The misfolding of proteins is the basis for a number of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Our findings are an important step toward the development of innovative prevention and treatment strategies for such diseases."


Dr. Thomas and Dr. Bergeron, together with graduate student Sean Taylor and post-doctoral fellow Andrew Ferguson, showed that the enzyme UDP-glucose:glycoprotein glucosyltransferase (UGGT) can sense specific regions of disorder and activity of proteins – key steps to recognizing misfolded proteins and removing them from the cells.

The paper and accompanying News and Views are currently available online.


This study was supported by research grants from the Canadian Institutes of Health Research.

Dr. David Thomas (http://www.mcgill.ca/biochemistry/department/faculty/thomas/) is the Chair of the McGill Department of Biochemistry and holds a Canada Research Chair in Molecular Genetics. Dr. Thomas’ research focuses on cell signaling pathways and their role in infectious diseases, and on molecular chaperone systems in the endoplasmic reticulum.

McGill University (www.mcgill.ca) is Canada’s leading research-intensive university and has earned an international reputation for scholarly achievement and scientific discovery. The 21 faculties and professional schools offer more than 300 programs, from the undergraduate to the doctoral level, and our professors have received their education from leading academic centres around the world. There are approximately 23,000 full- and part- time undergraduate students and 7,000 full- and part-time graduate students. McGill was recently named Canadian Research University of the Year in the Medical/Doctoral category based on research funding and publication information compiled by Research Infosource.

The CIHR (www.cihr-irsc.gc.ca) is Canada’s premier agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened health care system. CIHR’s Institute of Neurosciences, Mental Health and Addiction supports research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.

Sandra McPherson | McGill University
Further information:
http://www.mcgill.ca/biochemistry/department/faculty/thomas/
http://www.mcgill.ca
http://www.cihr-irsc.gc.ca

More articles from Life Sciences:

nachricht MicroRNA helps cancer evade immune system
19.09.2017 | Salk Institute

nachricht Ruby: Jacobs University scientists are collaborating in the development of a new type of chocolate
18.09.2017 | Jacobs University Bremen gGmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>